Ledger.Open graph →
SEC Form D · Amendment · filed October 30, 2013

Axsome Therapeutics, Inc

Offering
$4.0M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Tad O'Donnell · Minneapolis, MNExec · DirectorRick R. Lee · Owings Mills, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗